Invention Grant
US09175058B2 Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases
有权
可溶性免疫反应抑制多肽和多发性硬化症等自身免疫性疾病的治疗
- Patent Title: Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases
- Patent Title (中): 可溶性免疫反应抑制多肽和多发性硬化症等自身免疫性疾病的治疗
-
Application No.: US11570221Application Date: 2005-06-09
-
Publication No.: US09175058B2Publication Date: 2015-11-03
- Inventor: Staley A. Brod
- Applicant: Staley A. Brod
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2005/020265 WO 20050609
- International Announcement: WO2005/123107 WO 20051229
- Main IPC: C07K14/52
- IPC: C07K14/52 ; A61K38/17
Abstract:
The present invention provides methods of treating multiple sclerosis, type 1 diabetes mellitus and other autoimmune diseases by administering a soluble immune response suppressor (SIRS) peptide or a variant thereof to an individual having such disease. The SIRS peptide or variant reduces the severity of or frequency of relapse of multiple sclerosis and reduces the inflammation associated with multiple sclerosis and other autoimmune diseases.
Public/Granted literature
- US20070185030A1 Immune response suppressor and treatment of multiple sclerosis Public/Granted day:2007-08-09
Information query
